Vaccines

A curated collection of articles examining critical questions and advancements in vaccine science and policy.

Why we need to shift from reactive to proactive measures in tackling global health challenges.

Maintaining the stability of vaccines over time and during temperature excursions is a crucial aspect of production, transport, and delivery.

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

Here’s how five companies are innovating in the cancer vaccine space.

Cancer vaccines are compelling but there are challenges that must be faced. Experts give their view.

An interview with Debra Weiss, Chief Operating Officer at the Bill & Melinda Gates Medical Research Institute.

What’s all this talk of cancer vaccines? We find out how they work – and how mRNA has boosted the field – with the help of five experts.

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?